Medtronic, Capricor Therapeutics deal

Capricor purchased Medtronic’s patent related to the formulation and pump delivery of natriuretic

Read the full 136 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE